FDA Warns Companies about Processing, Distributing and Marketing Unapproved Stem Cell Products
By EsqSocial Corporation 15/01/20
The U.S. Food and Drug Administration (FDA) has issued three letters (one warning letter and two untitled letters) over the last two months of 2019 directed at four different companies focused on the processing, distributing, and marketing of...
By: Drinker Biddle & Reath LLP